Business profile
Indian pharmaceutical company making medicines for respiratory, chronic and acute conditions, selling in India, North America, South Africa and other markets.
SectorPharma
CountryIndia
Listed onNSE, BSE
Latest quarterQ2 FY27
Latest results · Q2 FY27
Revenue₹7,404.00 cr
−2.4% YoY
Net profit₹878.00 cr
−35.0% YoY
Quarterly results
| ₹ crore | Q2 FY26 | Q2 FY27 |
|---|---|---|
| Revenue | 7,589 | 7,404 |
| Net profit | 1,351 | 878 |
| Profit margin | 17.8% | 11.9% |
| Revenue growth YoY | — | −2.4% |
| Profit growth YoY | — | −35.0% |
OneTrader reports
- Top Earnings Today, October 27, 2026: Cipla Profit Falls as Several Companies Post Q2 Growth
- Stocks to Watch Today: October 27, 2026 – L&T, Maruti Suzuki, Bajaj Auto and More
- Top 10 Mid Cap Stocks in India by Market Capitalization
- Stocks to Watch Today: UltraTech Cement, Power Grid, Cipla and More
- Stocks to Watch Today: Groww, Cipla, Varun Beverages and More
More in Pharma
Anlon HealthcareDr Reddy's LaboratoriesGland PharmaMankind PharmaMorepen LaboratoriesOneSource Specialty PharmaPiramal Pharma
India figures in ₹ crore. YoY = change versus the same quarter last year. Figures are taken from company results as reported in OneTrader articles. For information only, not investment advice.